Assess whether pediatric studies are necessary or waivable (d246ba)

Situation

In a mid-size sponsor after a complete response letter, complete-response-letter deficiency list is the evidence after an FAERS cluster in a demographic the trials under-enrolled. Pharmacovigilance medical reviewer has to pick Pediatric studies are necessary or Waivable for this Pharma & Life Sciences CMC and Development Pathways close using complete-response-letter deficiency list.

Decision

Pharmacovigilance medical reviewer in a mid-size sponsor after a complete response letter must choose Pediatric studies are necessary / Waivable using complete-response-letter deficiency list after an FAERS cluster in a demographic the trials under-enrolled.

Hypotheses to test

• An FAERS cluster in a demographic the trials under-enrolled is noise around an already-controlled CMC and Development Pathways process in a mid-size sponsor after a complete response letter, given complete-response-letter deficiency list.
• An FAERS cluster in a demographic the trials under-enrolled is the event in complete-response-letter deficiency list that forces Pediatric studies are necessary for pharmacovigilance medical reviewer under Pharma & Life Sciences.
• Complete-response-letter deficiency list shows a one-file miss after an FAERS cluster in a demographic the trials under-enrolled, not a CMC and Development Pathways program failure.
• Complete-response-letter deficiency list cannot decide pediatric studies are necessary yet after an FAERS cluster in a demographic the trials under-enrolled; hold is the only Pharma & Life Sciences close a mid-size sponsor after a complete response letter can defend.

Analysis required

• Separate an isolated adverse event from a systemic quality issue.
• Test a protocol deviation versus a safety signal versus a filing gap on pediatric studies are necessary.
• Check whether complete-response-letter deficiency list supports the labeled claim pharmacovigilance medical reviewer would keep.
• For this Pharma & Life Sciences CMC and Development Pathways file, read complete-response-letter deficiency list against an FAERS cluster in a demographic the trials under-enrolled and write the one fact that would move pediatric studies are necessary for pharmacovigilance medical reviewer.

Recommendation